Pfizer Inc March 16, 2022 11:39 am

Pfizer Requests FDA Authorization for 2nd Booster in Seniors

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

Local

2:38

New Jersey releases review of response to COVID-19 pandemic
2:28

COVID, Flu, and RSV cases on the rise during holiday season
2:06

COVID cases on the rise ahead of holiday rush
3:06

NYC tourism tips: Here's the experts' guide to this holiday season
1:52

Bumpy rollout for new COVID vaccine
Exit mobile version